A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, Ph.D., has discovered a new therapeutic target for neuroendocrine prostate cancer, a rare and hard-to-treat ...

and neuroendocrine tumors (NETs), which are neoplasms that arise from cells of the endocrine and nervous systems. Cushing syndrome (CS) is defined by signs and symptoms caused by hypercortisolism.